U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 1,528 records

Showing results for "drugs".

  1. EHC Protocol: Making Healthcare Safer IV: Deprescribing to Reduce Medication Harms in Older Adults (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/deprescribing-protocol.pdf
    July 01, 2023 - approach, known as deprescribing, is defined as a “systematic process of identifying and discontinuing drugs … Drugs Aging. 2013 Oct;30(10):793-807. doi: 10.1007/s40266-013-0106-8. PMID: 23912674. 10.

  2. App-F2-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - TCA_PCT Table F-2a. Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Cardiac Rhythm Abnormalities: Specific AE Cardiac Rhythm Abnormalities: n Cardiac Rhythm Abnormalities: N N Randomized Cognitive Eff…

  3. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
    December 11, 2012 - Status UA/NSTEMI-Related FDA Indications Plavix® Clopidogrel Bristol Myers Squibb Sanofi Pharmaceuticals … thrombotic CV events in patients with ACS (UA, NSTEMI, STEMI) Arixtra® Fondaparinux GlaxoSmithKline Pharmaceuticals … in patients with nonvalvular atrial fibrillation Pradaxa® Dabigatran Boehringer Ingelheim Pharmaceuticals … Pfizer 2.5 mg 5 mg Twice daily Oral Not currently FDA approved Protonix® Pantoprazole Wyeth Pharmaceuticals … patients on dual antiplatelet therapy to reduce the risk of bleeding Prevacid® Lansoprazole Takeda Pharmaceuticals

  4. Evidence Summary Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-evidence-summary_0.pdf
    October 01, 2021 - preferred treatment of chronic pain.1,2 However, recent systematic reviews found that several nonopioid drugs … qualitative and indirect comparisons with very limited evidence on cannabis products relative to the other drugs

  5. Monitoring-Programs-Rapid-Research-Appendix-C (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-rapid-research-appendix-c.xlsx
    May 31, 2025 - and transportation which includes: a) Consolidated Services Center for management and distribution of pharmaceuticals

  6. Searching for Relevant Studies (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/searching.ppt
    January 01, 2011 - Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. … Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. … or may be incompletely published elsewhere Good check for publication bias Regulatory Web sites: Drugs … That is because the approval process for new drugs and devices requires submission of data that may not … Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. Sassi F, Archard L, McDaid D. 

  7. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/tinnitus_research-protocol.pdf
    February 22, 2012 - Tinnitus can also be a side effect of potentially ototoxic drugs, ranging from aspirin taken to alleviate … arthritic pain to aminoglycoside antibiotics and life-saving drugs used to treat cancer.4 These effects … While drugs are used for tinnitus, there is no drug that has been approved specifically for its treatment … Behavioral methods should be used before considering the use of drugs. … Drugs can be used to treat comorbid conditions such as anxiety and depression.

  8. Appendix C: Fiber Intake and Laxation in People With Normal Bowel Function Report (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-prepub-final-research-appendix-c.xlsx
    January 01, 2024 - health legume allergy; milk or lactose intolerance; chronic diseases; pregnancy; lactation; intake of pharmaceuticals … lactose intolerance, chronic bowel diseases, pregnancy, lactation, and the intake of blood lipid–lowering pharmaceuticals … funding of study NR 18–55 years, BMI: 18.5-30 kg/m2, healthy and free of chronic diseases, avoid any pharmaceuticals … Antibiotics, anti-inflammatory/immune suppressive drugs and spasmolytics use.* (e.g. hospital or nursing … Antibiotics, anti-inflammatory/immune suppressive drugs and spasmolytics use. 4 wk 4-6 wk 28/28 d Days

  9. Fiber-Intake-Final-Appendix-C (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-final-appendix-c.xlsx
    January 01, 2024 - health legume allergy; milk or lactose intolerance; chronic diseases; pregnancy; lactation; intake of pharmaceuticals … lactose intolerance, chronic bowel diseases, pregnancy, lactation, and the intake of blood lipid–lowering pharmaceuticals … funding of study NR 18–55 years, BMI: 18.5-30 kg/m2, healthy and free of chronic diseases, avoid any pharmaceuticals … Antibiotics, anti-inflammatory/immune suppressive drugs and spasmolytics use.* (e.g. hospital or nursing … Antibiotics, anti-inflammatory/immune suppressive drugs and spasmolytics use. 4 wk 4-6 wk 28/28 d Days

  10. Revised Protocol - Opioids 12 13 13[1] (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-pain-opioid-treatment_research-protocol.pdf
    December 19, 2013 - http://www.fda.gov/downloads/Drugs/DrugSafet y/InformationbyDrugClass/UCM348818.pdf. 29. … www.effectivehealthcare.ahrq.gov http://www.uspreventiveservicestaskforce.org/us http://www.fda.gov/downloads/Drugs

  11. DARTNet Summary Report (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-ambulatory-therapeutics_research.pdf
    July 01, 2009 - (cross-walked) to one of several coding systems; ICD-9 CM for diagnoses, RxNORM and GCN codes for drugs … of SNOMED CT versus commercially available drug codes for group classifications and combination drugs … the DARTNet Diabetes Replication Cohort was generally similar to those seen in phase 1 related to drugs … study will describe the patterns of use of antidepressants and combinations of other psychotropic drugs … research, DARTNet’s ultimate aim is to improve the understanding of the effectiveness of various drugs

  12. Appendix A. Long COVID Models of Care – Grey literature sources (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-covid-appendix-a.pdf
    December 01, 2022 - Physical Medicine & Rehabilitation; ACC = American College of Cardiology; CADTH = Canadian Agency for Drugs

  13. Future Research Needs Document (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
    October 25, 2010 - conduct and support research on the comparative outcomes, clinical effectiveness, and appropriateness of pharmaceuticals … Drugs based on a person's genetics 37.5% (3) 50.0% (4) 12.5% (1) Q12. … Gene-based drugs 54.5% (6) 9.1% (1) 36.4% (4) Q12. … Drugs that target specific molecular cancer pathways 62.5% (5) 37.5% (3) 0 (0) Q13. … Randomized controlled trials I Drug development 224 Molecular targeted drugs specific to

  14. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
    April 06, 2010 - Summary of Protocol Amendments 04-02-2010 Amendment I Including Drugs Recently Approved by the … The search and protocol will be updated to include all FDA- approved drugs and indications, as of March … The combinations include one of the following drugs: • Metformin, • Thiazolidinediones (TZDs), •

  15. S116 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s116.pdf
    October 01, 2007 - Helen Mogun, MS, and Sebastian Schneeweiss, MD, ScD Background: Postmarketing studies of prescription drugs … Violations of the exclusion restriction can occur if physicians who more frequently use the older drugs … Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly

  16. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_executive.pdf
    July 01, 2009 - in RCTs of rhythm vs. rate control was performed, a strategy of rhythm control with anti-arrhythmic drugs … Radiofrequency ablation vs. open surgical procedures Any 0 Radiofrequency ablation vs. antiarrhythmic drugs … Studies rated “good” must have reported the atrial fibrillation recurrence rate off anti- arrhythmic drugs

  17. Making Healthcare Safer IV: Summary of Findings, 2023-2024 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-1-year-final-report-updated-title_0.pdf
    May 01, 2024 - available at: https://effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk- drugs-rapid-response.pdf … https://effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf … https://effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf

  18. Management of suspected opioid overdose with Naloxone by Emergency Medical Services personnel (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/emt-naloxon_research-protocol.pdf
    November 29, 2016 - race, type of opioid involved in overdose, dose of opioid involved in overdose, presence of other drugs … race, type of opioid involved in overdose, dose of opioid involved in overdose, presence of other drugs

  19. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
    June 01, 2011 - Currently, three classes of drugs that interact with this system are used to inhibit the effects of angiotensin … (2) Relative persistence with drug therapy across the different classes of drugs.

  20. Crosscutting-Horizon-Scan-High-Impact-1506 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists five topics for which (1) preliminary phase III data for drugs were … It differentiated 100% of multiple drugs and doses taken simultaneously by type and by dose.
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites